1106822

Hikma Pharmaceuticals USA Inc. — FEI 2220525

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 10, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cherry Hill, NJ (United States)